Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine
- PMID: 34171435
- PMCID: PMC8219312
- DOI: 10.1016/j.jhep.2021.06.014
Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine
Keywords: COVID-19 vaccine; autoimmune hepatitis; immune mediated.
Conflict of interest statement
Conflict of interest The authors declare no conflict of interest. Please refer to the accompanying ICMJE disclosure forms for further details.
Figures
Comment in
-
Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: One or even several swallows do not make a summer.J Hepatol. 2021 Nov;75(5):1256-1257. doi: 10.1016/j.jhep.2021.08.001. Epub 2021 Aug 10. J Hepatol. 2021. PMID: 34384822 Free PMC article. No abstract available.
Comment on
-
Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?J Hepatol. 2021 Jul;75(1):222-224. doi: 10.1016/j.jhep.2021.04.003. Epub 2021 Apr 20. J Hepatol. 2021. PMID: 33862041 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
